CN102212577B - Method for catalytic synthesis of vitamin E succinate by utilizing yeast display lipase - Google Patents
Method for catalytic synthesis of vitamin E succinate by utilizing yeast display lipase Download PDFInfo
- Publication number
- CN102212577B CN102212577B CN2011101088162A CN201110108816A CN102212577B CN 102212577 B CN102212577 B CN 102212577B CN 2011101088162 A CN2011101088162 A CN 2011101088162A CN 201110108816 A CN201110108816 A CN 201110108816A CN 102212577 B CN102212577 B CN 102212577B
- Authority
- CN
- China
- Prior art keywords
- lipase
- vitamin
- yeast display
- succinate
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Abstract
The invention discloses a method for catalytic synthesis of vitamin E succinat by utilizing yeast display lipase, and the method comprises the following steps: dissolving vitamin E and succinic anhydride in an organic solvent, adding the yeast display lipase, reacting at 50-60 DEG C for 10-14 hours under an anaerobic condition, and separating and purifying, thus obtaining the vitamin E succinate. The preparation method of the yeast display lipase comprises the following steps: transforming the recombinant plasmid subjected to linear treatment into a Pichia Pastoris yeast GS115, inoculating the obtained transformants into a BMMY (buffered methanol-complex medium), inducing and culturing for 72-144 hours, carrying out centrifugal collection on thallus, washing, and carrying out organism printing and frozen drying on the washed thallus, thus obtaining the yeast display lipase. Through displaying lipase outside cells, and utilizing the lipase to conduct catalytic synthesis of the vitamin E vitamin E succinate, the conversion efficiency can be improved, the reaction time is shortened, and the production cost is lowered.
Description
Technical field
The present invention relates to technical field of bioengineering, relate in particular to the method that a primary yeast display lipase catalyzes and synthesizes VE-succinate.
Background technology
Natural VE (tocopherol), be important liposoluble vitamin and the natural antioxidants that has different physiological roles in the human body, it have significantly anti-oxidant, eliminate interior free yl, eliminate sexual dysfunction, stimulate circulation, prevent early ageing, preventing cancer takes place, improve functions such as immunity of organisms, is a kind of extremely important medicine and health material.Yet natural VE is easy to oxidized, and the vitamin-E product on the market is the stable derivatives through over-churning mostly.Vitamin-E acetic acid, ester VE succinic acid monoester are main vitamin-E esterification derivatives.Wherein VE succinic acid monoester (vitamin E succinate) is except the function with general vitamin-E, also have some unique pharmacological functions are arranged, be good prolactin and secretion of growth hormone promotor as it, therefore the market value of tocofecol succinic acid monoesters is far above general vitamin-E, alpha-tocopherol is changed into succinate, is the effective way that improves the vitamin-E added value of product.Realize that at present this conversion has chemical method and biological enzyme, because chemical method exists conversion condition harshness (strong acid, base catalysis, High Temperature High Pressure), no specificity, product complexity, drawbacks such as by product is many, separation is difficult, poor stability, biological enzyme is more and more favored.Lipase be present VITAMIN ester synthetic in most popular enzyme, but production cost height, numerous and diverse time-consuming its commercial applications of having limited to greatly of immobilization process.
Summary of the invention
The invention provides the method that a primary yeast display lipase catalyzes and synthesizes VE-succinate, can significantly reduce the VE-succinate production cost, reach higher esterification efficient and productive rate simultaneously.
One primary yeast display lipase catalyzes and synthesizes the method for VE-succinate, comprising:
Vitamin-E and succinyl oxide are dissolved in the organic solvent, add the yeast display lipase, in 50～60 ℃ of reactions 10～14 hours, separation, purifying made VE-succinate under the oxygen free condition.
Preferably, described organic solvent is normal hexane.
Preferably, the add-on of vitamin-E, succinyl oxide and yeast display lipase is respectively 20～100g, 50～100g, 50～100g in every liter of organic solvent.
Stir speed (S.S.) is 200～250 rev/mins.
Described separation, purifying are: reaction solution is centrifugal, get supernatant liquor, and rotary evaporation is removed organic solvent, is dissolved in normal hexane, recrystallization after the washing.
Described yeast display lipase prepares by the following method:
To change pichia spp (Pichia pastoris) GS115 through the recombinant plasmid of linearization process over to, the gained transformant is inoculated in the BMMY substratum, inducing culture is centrifugal collection thalline after 72～144 hours, and thalline makes the yeast display lipase through flushing, biological trace and lyophilize;
Described recombinant plasmid is by initial carrier pPIC9K and insert the lipase gene in MF α 1 signal peptide downstream among the initial carrier pPIC9K successively and the cell walls α agglutinin gene of pichia spp GS115 is formed.
Described lipase gene can be selected for use and be the sequence of AF229435 Genbank number, and pichia spp (Pichia pastoris) GS115 is commercially produced product, can buy from Invitrogen company.Genbank number of its cell walls α agglutinin gene sequence is M28164.
Carrier pPIC9K is commercially produced product (as Invitrogen company), and there is MF α 1 signal peptide sequence in it, and (Genbank number: M17301), there is the AOX1 promotor in the signal peptide sequence upstream (Genbank number: Z46233) in this carrier simultaneously.The purpose of recombinant plasmid linearization process be for born of the same parents in genome generation homologous recombination, improve expression stability.
Preferably, the used part of described biological trace is oleic acid, and it can the inducible enzyme structural modification, improves transformation efficiency.
The present invention is by importing pichia spp cell GS115 with lipase gene and cell walls α agglutinin gene, and after the pichia spp cell induction was cultivated, lipase was expressed justacrine outside born of the same parents, utilizes cell walls α lectin that this lipase is fixed on cell surface simultaneously.Utilize this yeast display lipase that esterification is carried out catalysis, can effectively improve operational stability, thermotolerance and repeatability, because this enzyme of specificity of enzyme reaction can suppress the generation of side reaction significantly, whole transformation efficiency (in vitamin-E) is more than 80%.
Embodiment
Embodiment 1 preparation yeast display lipase
Method by synthetic, the lipase gene of synthetic Rhizopus oryzae (Rhizopus oryzae) (Genbank number: AF229435) and the cell walls α agglutinin gene (Genbank number is M28164) of pichia spp GS115, add connection peptides sequence GSSGGSGGSGGSGGSGS (linker) at lipase gene C end simultaneously, obtain nucleotide sequence pro-ROL-linker-α-agglutinin after the connection, add EcoR I and Not I restriction enzyme site simultaneously at the sequence two ends, wherein pro-ROL is lipase gene, and α-agglutinin is cell walls α agglutinin gene.
Be template with above-mentioned artificial synthesized sequence, utilize following primer right, carry out pcr amplification,
Upstream primer: 5 '-AAGGAAAAAAGAATTCGTTCCAGTTTCTGG-3 ';
Downstream primer: 5 '-TTTTCCTTTTGCGGCCGCTAATGAAACG-3 '
The PCR reaction system is: template DNA is 1 μ l, high-fidelity DNA polymerase 0.5 μ l, and dNTP (50mM) 0.4 μ l, each 0.5 μ l of upstream and downstream primer, 10 * PCR damping fluid, 5 μ l add water to 50 μ l.
The PCR operational conditions is: 94 ℃ 3 minutes, 35 circulations (94 ℃ 30 seconds, 60 ℃ 1 minute, 72 ℃ 30 seconds), 72 ℃ 10 minutes.
With EocR I and Not I simultaneously enzyme cut PCR product and pPIC9K plasmid, and under the effect of T4 ligase enzyme, spend the night and be connected to form the pPIC9K-ROL plasmid, by the electrophoresis check and reclaim plasmid.For making goal gene and pichia spp GS115 that His 4 unit points displacement reorganization take place, carry out linearization for enzyme restriction with the pPIC9K-ROL plasmid of Sal I and handle.The about 15 μ l of goal gene that linearization for enzyme restriction is handled well join in the previously prepd pichia spp GS115 competent cell, change in the electric revolving cup ice bath 15min over to, then at 1500V, 400 Ω, the 10ms that shocks by electricity under the 25uF condition, and the sorbyl alcohol of the about 1ml precooling of adding.The electricity of the above-mentioned mixing about 400 μ l of thing that change the line of production are applied on the MD flat board, and the screening positive transformant is applied to positive transformant on the G418 flat board of different concns then, the resistance screening of G418 is gone out the positive recombinant bacterial strain of multiple copied of Mut phenotype according to positive transformant.
The positive recombinant bacterial strain of multiple copied is seeded in fermentation culture 30h in the BMGY substratum, centrifugal collecting cell; Again cell is placed the BMMY substratum inducing culture 144h that contains 0.5% (volume percent) methyl alcohol, centrifugal collecting cell, after the water flushing, be seeded to 30 ℃ of cultivation 120h in the YGC substratum, 3000g collected thalline in centrifugal minute then, wash with 50mM pH7.0 phosphoric acid buffer again behind the distilled water wash, mix with 2 times of volume oleic acid then, after-80 ℃ of following pre-freezes again through the dry 24h of German Christ vacuum freeze drier, remove oleic acid with hexane wash, carry out vacuum-drying more again and remove hexane, namely obtain the yeast display lipase of handling through biological trace.
Embodiment 2 yeast display lipases catalyze and synthesize VE-succinate
Example 1 is got vitamin-E 0.472g, succinyl oxide 0.5g, adds the ground triangular flask that contains the 10mL normal hexane, and mixing, preheating 10min add yeast display lipase 0.5g then, fill N
2Sealing, place 85-1 type magnetic stirring apparatus to stir and begin reaction, rotating speed is 250 rev/mins, temperature of reaction remains on 45 ℃, reaction stops behind the 12h stirring, and the yeast display lipase is removed in centrifugation, gets supernatant liquor and is rotated evaporation and removes organic solvent, add normal hexane after washing 3 times and get the VE-succinate product in 4 ℃ of crystallizations, oven dry, pulverizing get final product.
Example 2 is got vitamin-E 0.656g, succinyl oxide 0.7g, adds the ground triangular flask that contains the 10mL normal hexane, and mixing, preheating 10min add yeast display lipase 1g then, fill N
2Sealing, place 85-1 type magnetic stirring apparatus to stir and begin reaction, rotating speed is 200 rev/mins, temperature of reaction remains on 50 ℃, reaction stops behind the 12h stirring, and the yeast display lipase is removed in centrifugation, gets supernatant liquor and is rotated evaporation and removes organic solvent, add normal hexane after washing 3 times and get the VE-succinate product in 4 ℃ of crystallizations, oven dry, pulverizing get final product.
Embodiment 3 adopts traditional chemical method synthesising complex E succinate
Get vitamin-E 0.472g, succinyl oxide 0.5g, add the ground triangular flask that contains the 10mL normal hexane, mixing, preheating 10min fill N
2Sealing, place 85-1 type magnetic stirring apparatus to stir and begin reaction, rotating speed is 250 rev/mins, temperature of reaction remains on 45 ℃, stop to stir behind the reaction 12h, get supernatant liquor and be rotated evaporation and remove organic solvent, add normal hexane after wash 3 times to get the VE-succinate product in 4 ℃ of crystallizations, oven dry, pulverizing get final product.
Embodiment 4 measures conversion yield and transformation efficiency
Get the unsegregated reaction product of 1mL, centrifugal removal catalyzer, the rotary evaporation solvent accurately is settled to 10mL with 100% methyl alcohol, and this solution is measured each concentration of component of solution with high performance liquid chromatography (HPLC) behind the organic membrane filtration of 0.22 μ m.The HPLC condition is as follows: Agilent Technologies 1200 series of high efficiency liquid chromatography liquid, chromatographic column: Grace Prevail Organic Acid 5u150mm * 4.6mm, column temperature: 40 ℃, moving phase: methanol/phosphoric acid (85/15/0.1), flow velocity: 1mL/min, sample size: 10 μ L, detect wavelength: 280nm.
The transformation efficiency calculation formula is as follows:
Transformation efficiency=C vitamin E-C ester/C vitamin E * 100%.
In the formula: C ester is the concentration of VE-succinate in the HPLC working sample, and C vitaminE is the concentration of vitamin-E in the preceding sample of reaction.
By the aforesaid method detection computations, among the embodiment 2, the transformation efficiency of example 1 synthesising complex E succinate reaches 80%, and the transformation efficiency of example 2 synthesising complex E succinates reaches 82%.And the transformation efficiency of embodiment 3 employing traditional chemical method synthesising complex E succinates only is 68%.
Claims (1)
1. a primary yeast display lipase catalyzes and synthesizes the method for VE-succinate, comprising:
The lipase gene of synthetic Rhizopus oryzae (Rhizopus oryzae) and the cell walls α agglutinin gene of pichia spp GS115, then add the gene fragment of coding connection peptides sequence GSSGGSGGSGGSGGSGS at lipase gene C end, connect and obtain nucleotide sequence pro-ROL-linker-α-agglutinin, pro-ROL represents lipase gene, be for Genbank number: AF229435, α-agglutinin represents cell walls α agglutinin gene, be for Genbank number: M28164, the gene fragment of linker representative coding connection peptides;
Be template with the artificial synthesized sequence, utilize following primer right, carry out pcr amplification;
Upstream primer: 5 '-AAGGAAAAAAGAATTCGTTCCAGTTTCTGG-3 ';
Downstream primer: 5 '-TTTTCCTTTTGCGGCCGCTAATGAAACG-3 ';
The PCR reaction system is: template DNA is 1 μ L, archaeal dna polymerase 0.5 μ L, and the dNTP0.4 μ L of 50mM, each 0.5 μ L of upstream and downstream primer, 10 * PCR damping fluid, 5 μ L add water to 50 μ L;
The PCR operational conditions is: 94 ℃ 3 minutes; 35 circulations, each circulation is: 94 ℃ 30 seconds, 60 ℃ 1 minute, 72 ℃ 30 seconds; 72 ℃ 10 minutes;
With EocR I and Not I simultaneously enzyme cut PCR product and pPIC9K plasmid, and under the effect of T4 ligase enzyme, spend the night and be connected to form the pPIC9K-ROL plasmid; Carrying out linearization for enzyme restriction with the pPIC9K-ROL plasmid of Sal I handles, the about 15 μ L of goal gene that linearization for enzyme restriction is handled well join in the previously prepd pichia spp GS115 competent cell, change in the electric revolving cup, ice bath 15min, then at 1500V, 400 Ω, the 10ms that shocks by electricity under the 25 μ F conditions, and the sorbyl alcohol of the about 1mL precooling of adding;
The electricity of the mixing thing 400 μ L that change the line of production are applied on the MD flat board, and the screening positive transformant is applied to positive transformant on the G418 flat board of different concns then, the resistance screening of G418 is gone out the positive recombinant bacterial strain of multiple copied of Mut phenotype according to positive transformant;
The positive recombinant bacterial strain of multiple copied is seeded in fermentation culture 30h in the BMGY substratum, centrifugal collecting cell; Again cell is placed the BMMY substratum inducing culture 144h that contains volume percent 0.5% methyl alcohol, centrifugal collecting cell, after the water flushing, be seeded to 30 ℃ of cultivation 120h in the YGC substratum, the centrifugal collection thalline of 3000g then, wash with 50mM pH7.0 phosphoric acid buffer again behind the distilled water wash, mix with 2 times of volume oleic acid then, after-80 ℃ of following pre-freezes again through the dry 24h of German Christ vacuum freeze drier, remove oleic acid with hexane wash, namely obtain the yeast display lipase of handling through biological trace;
Get vitamin-E 0.656g, succinyl oxide 0.7g, add the ground triangular flask that contains the 10mL normal hexane, mixing, preheating 10min add yeast display lipase 1g then, fill N
2Sealing, place 85-1 type magnetic stirring apparatus to stir and begin reaction, rotating speed is 200 rev/mins, temperature of reaction remains on 50 ℃, reaction stops behind the 12h stirring, and the yeast display lipase is removed in centrifugation, gets supernatant liquor and is rotated evaporation and removes organic solvent, add normal hexane after washing 3 times and get the VE-succinate product in 4 ℃ of crystallizations, oven dry, pulverizing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101088162A CN102212577B (en) | 2011-04-28 | 2011-04-28 | Method for catalytic synthesis of vitamin E succinate by utilizing yeast display lipase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101088162A CN102212577B (en) | 2011-04-28 | 2011-04-28 | Method for catalytic synthesis of vitamin E succinate by utilizing yeast display lipase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102212577A CN102212577A (en) | 2011-10-12 |
| CN102212577B true CN102212577B (en) | 2013-08-14 |
Family
ID=44744109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101088162A Expired - Fee Related CN102212577B (en) | 2011-04-28 | 2011-04-28 | Method for catalytic synthesis of vitamin E succinate by utilizing yeast display lipase |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102212577B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020072326A (en) * | 2001-03-08 | 2002-09-14 | 봉 환 정 | Fermentation Technique for the Production of High Concentration Ethanol from Food Wastes |
| CN101475968B (en) * | 2009-01-23 | 2011-04-20 | 北京科技大学 | Method for synthesizing natural alpha-tocofecol tocopherol acid succinate by using lipase |
-
2011
- 2011-04-28 CN CN2011101088162A patent/CN102212577B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102212577A (en) | 2011-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102212601B (en) | Method for performing catalytic synthesis of vitamin A palmitate by using yeast display lipase | |
| CN104031899B (en) | A kind of lipase and application thereof | |
| CN113308378B (en) | Ganoderma lucidum strain for high-yield ergothioneine and application thereof | |
| CN102212577B (en) | Method for catalytic synthesis of vitamin E succinate by utilizing yeast display lipase | |
| CN102212572B (en) | Method for catalytically synthesizing L-ascorbyl oleate with yeast display lipase | |
| CN102226209B (en) | Method for catalyzing and synthesizing vitamin E oleate by using lipase displayed on yeast | |
| CN102212576B (en) | Method for synthesizing vitamin E linoleate by catalysis of yeast display lipase | |
| CN102212570B (en) | Method for catalytically synthesizing vitamin C conjugated linoleate with yeast display lipase | |
| CN102212586B (en) | Method for catalytically synthesizing starch sodium alkenylsuccinate (SSAS) with yeast display lipase | |
| CN102212580B (en) | Method for catalytic synthesis of glucose laurate by utilizing yeast display lipase | |
| CN102212575B (en) | Method for synthesizing L-ascorbyl palmitate by catalysis of yeast display lipase | |
| CN104388483A (en) | Method for preparing diglyceride through solventless continuous enzymolysis | |
| CN102212574B (en) | Method for catalytic synthesis of L-ascorbic acid linoleate by utilizing yeast display lipase | |
| CN102212583B (en) | Method for catalyzing and synthesizing octenyl succinic anhydride modified starch ester through yeast show lipase | |
| CN102212591B (en) | Method for catalyzing and synthesizing sucrose stearate through yeast show lipase | |
| CN102212579B (en) | Method for catalyzing and synthesizing glucose myristate through yeast show lipase | |
| CN102212602B (en) | Method for synthesizing vitamin A lactate by catalysis of yeast display lipase | |
| CN102212584B (en) | Method for catalyzing and synthesizing starch acetate through yeast show lipase | |
| CN102212573B (en) | Method for catalytically synthesizing L-ascorbyl docosahexaenoate with yeast display lipase | |
| CN102212571B (en) | Method for catalytically synthesizing L-ascorbyl EPA ester with yeast display lipase | |
| CN102212592B (en) | Method for catalyzing and synthesizing maltose laurate through yeast show lipase | |
| CN102212590B (en) | Method for catalytically synthesizing sucrose palmitate with yeast display lipase | |
| CN102212593B (en) | Method for performing catalytic synthesis of maltose stearate by using yeast display lipase | |
| CN102212578B (en) | Method for synthesizing fructose palmitate by catalysis of yeast display lipase | |
| CN102212585B (en) | Method for catalytic synthesis of starch phosphate by utilizing yeast display lipase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130814 Termination date: 20160428 |